Becker's Healthcare September 22, 2022
The Inflation Reduction Act, signed by President Joe Biden on Aug. 16, includes several changes to Medicare drug pricing — some of which may increase Medicaid drug spending, according to Kaiser Family Foundation.
In a policy briefing, KFF analyst Elizabeth Williams said provisions in the Inflation Reduction Act that require drugmakers to pay rebates to the government if they raise prices higher than the rate of inflation for Medicare are expected to increase Medicaid spending on drugs.
These provisions take effect in 2023.
Medicaid already receives...
Today's Sponsors
Today's Sponsor